Petra Müller

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

ECE Group GmbH & Co. KG engages in the development and construction of commercial and industrial centers and properties. It offers general planning and contracting, architecture, construction management, project development and management, marketing and sales, leasing, refurbishment, center management, and master planning. The company was founded by Werner Otto in 1965 and is headquartered in Hamburg, Germany.

Part of Sartorius AG, Wave Biotech AG is a Swiss company that develops, produces, and sells single-use Wave bioreactors and Wavebags, along with complementary equipment for the biotechnological and pharmaceutical industry. The company is based in Tagelswangen, Switzerland. Wave Biotech was acquired by Sartorius Stedim Biotech GmbH on December 01, 2008.

Part of Sartorius AG, Sartorius Stedim Biotech GmbH is a company based in Goettingen, Germany. The CEOs are Helge Henning, Michaela Pischke. The German company was founded in 2007.

Filtration Technology Corp. manufactures oil and gas field machinery. The firm offers liquid filters for bag housings, including bag filters, pleated bag filters, and max-out conversion systems; liquid filters for cartridge housings, such as cartridge filters, pleated cartridge filters, and alternative replacement filters; and hydrocarbon removal filters, oil/water separation filter systems, and wastewater cleanup systems. It also provides technical services and support, and test and analysis services. The company was founded in 1987 and is headquartered in Houston, TX.

Part of Sartorius AG, Sartorius Corporate Administration GmbH provides management and administration services. The company is based in Goettingen, Germany. The CEO of the German company is Rainer Lehmann.

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.

Part of Sartorius AG, Sartorius Stedim BioOutsource Ltd. is a British company that provides contract testing services of biologic drugs and vaccines. The company is based in Glasgow, UK. The company was founded in 2007. The CEO is Hugo de Wit. Sartorius Stedim BioOutsource was acquired by Sartorius Stedim Biotech SA on April 17, 2015.

Part of Sartorius AG, Sartorius Korea Biotech Co., Ltd. is a South Korean company that provides engineering services. The company is based in Seongnam, South Korea. The company was founded in 2005. Duk-Sang Kim has been the CEO of the company since 2005.

BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon.

Sartorius Stedim Fmt SAS manufactures plastic packaging products. It serves to biopharmaceutical, chemical, food, and academic labs. The firm's product portfolio includes cell analysis, bioreactors, lab filtration, fluid management, and water purification. The company is headquartered in Aubagne, France.

ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.

Part of Sartorius AG, Albumedix Ltd. is a British science-driven company and recognized leader of albumin-enabled solutions. The company, based in Nottingham, UK, was founded in 1984 with a mission to empower excellence. Albumedix has supported its life-science partners in delivering safe doses of clinical and marketed therapeutics. The company's solutions include the world's only USP-NF compliant recombinant human albumin, client-centric development and compliance services, and drug-enhancing technologies. By challenging the status quo and striving for more, Albumedix enables the development and commercialization of advanced therapies and next-generation biopharmaceuticals. Albumedix is the world leader in recombinant human albumin and has developed a portfolio of products known as Recombumin®. Founded in 1973, the CEO of Albumedix is Jonas S. Moller. The company was acquired by Sartorius Stedim Biotech SA on September 30, 2022, for $500.47 million.

Part of Sartorius AG, Sartorius Stedim North America Holding GmbH provides financial services. The company is based in Goettingen, Germany. The CEO of the German company is Uwe Becker.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.

Part of Sia Partners SASU, Latham BioPharm Group, Inc. is a leading life science consulting company that works with pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies to solve complex business, regulatory, and product development challenges. The company was founded in 1996 by Peter Latham and is based in Elkridge, MD. LBG's core services include comprehensive functional expertise in vaccines, therapeutics, cell & gene therapy, medical devices, and diagnostics. The company provides technical expertise, quality oversight, strategic analysis, and knowledge management necessary to successfully navigate the complex roadmap of life sciences product development. LBG has helped clients identify, evaluate, fund, manage, and monetize opportunities, generating over $1 billion in non-dilutive funding and over $100 million in licensing fees and investments. Latham BioPharm Group was acquired by Sia Partners SASU on October 14, 2022.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.

Part of Sartorius AG, Sartorius Xell GmbH is a German company that specializes in providing solutions tailored to the specific requirements of cell lines, allowing them to achieve optimal product yields. The company, founded in 2009, is based in Schloß Holte-Stukenbrock, Germany. Xell's expertise lies in developing customized production processes, including cell culture media, feeds, and medical products. The company's team of highly skilled and motivated employees, with diverse scientific backgrounds, emphasizes a strong focus on technology and innovation. Sartorius Xell was acquired by Sartorius Stedim Biotech SA on July 29, 2021.